Berita

Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

Kamis, 07 Juli 2022 | 18:58 WIB
Merck in Advanced Talks to Buy Seagen in Nearly US$ 40 Billion Deal

ILUSTRASI. Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion. REUTERS/Mike Blake/Illustration/File Photo GLOBAL BUSINESS WEEK AHEAD - SEARCH GLOBAL BUSINESS 15 MAY FOR ALL IMAGES

Sumber: Wall Street Journal,Reuters | Editor: Anastasia Lilin Yuliantina

KONTAN.CO.ID - Drugmaker Merck & Co is in advanced talks to buy cancer-focused biotech company Seagen Inc in a deal that could be worth roughly US$ 40 billion or more. The Wall Street Journal reported on Wednesday.

The companies are discussing a price above US$ 200 a share for Seagen, the report said, citing people familiar with the matter.


Baca juga

IHSG
7.129,28
0.43%
-31,11
LQ45
1.012,04
0.62%
-6,29
USD/IDR
14.799
-0,51
EMAS
990.000
0,50%